Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder J.H. Whitney Equity Partners V Sells 2,419,035 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,419,035 shares of the firm’s stock in a transaction that occurred on Tuesday, June 30th. The stock was sold at an average price of $8.01, for a total transaction of $19,376,470.35. Following the transaction, the insider owned 10,112,123 shares of the company’s stock, valued at approximately $80,998,105.23. The trade was a 19.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.00, for a total transaction of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The shares were sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Trading Up 3.7%

AVAH traded up $0.33 during trading on Thursday, reaching $9.19. 1,002,532 shares of the stock traded hands, compared to its average volume of 1,480,237. The company has a quick ratio of 1.47, a current ratio of 1.47 and a debt-to-equity ratio of 5.35. The stock has a market capitalization of $2.00 billion, a PE ratio of 7.78, a P/E/G ratio of 0.88 and a beta of 1.89. The stock’s 50-day moving average is $7.25 and its 200 day moving average is $7.56. Aveanna Healthcare Holdings Inc. has a 12 month low of $3.73 and a 12 month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The firm had revenue of $647.91 million during the quarter, compared to analyst estimates of $613.22 million. The firm’s revenue for the quarter was up 15.9% on a year-over-year basis. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.65 earnings per share for the current year.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the company. AustralianSuper Pty Ltd bought a new position in shares of Aveanna Healthcare in the 3rd quarter worth $15,743,000. Vanguard Group Inc. increased its stake in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after purchasing an additional 1,535,351 shares in the last quarter. Algert Global LLC raised its holdings in Aveanna Healthcare by 120.1% during the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock worth $9,070,000 after buying an additional 557,898 shares during the last quarter. Quantbot Technologies LP raised its holdings in Aveanna Healthcare by 1,220.8% during the third quarter. Quantbot Technologies LP now owns 109,707 shares of the company’s stock worth $973,000 after buying an additional 101,401 shares during the last quarter. Finally, UBS Group AG lifted its stake in shares of Aveanna Healthcare by 149.4% in the fourth quarter. UBS Group AG now owns 394,182 shares of the company’s stock valued at $3,220,000 after buying an additional 236,152 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Analyst Upgrades and Downgrades

AVAH has been the subject of several recent analyst reports. Royal Bank Of Canada raised shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a research report on Wednesday, June 3rd. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research note on Friday, May 15th. Truist Financial raised their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a report on Wednesday, May 20th. Barclays decreased their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a research note on Monday, May 18th. Finally, BMO Capital Markets dropped their price objective on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $10.50.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.